Drugs / TISA-818
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07319351 | Oct 2023 → Mar 2025 | adult acute respiratory distress syndrome | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TISA-818 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07319351 ↗ |